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Chemical form (i.e., species) can influence metal toxicokinetics and toxicodynamics and 
should be considered to improve human health risk assessment. Factors that influence 
metal speciation (and examples) include: (1) carrier-mediated processes for specific 
metal species (arsenic, chromium, lead, and manganese), (2) valence state (arsenic, 
chromium, manganese, and mercury), (3) particle size (lead and manganese), (4) the 
nature of metal binding ligands (aluminum, arsenic, chromium, lead and manganese), 
(5) whether the metal is an organic versus inorganic species (arsenic, lead and 
mercury), and (6) biotransformation of metal species (aluminum, arsenic, chromium, 
lead, manganese, and mercury). The influence of speciation on metal toxicokinetics and 
toxicodynamics in mammals, and therefore the adverse effects of metals, is reviewed to 
illustrate how the physicochemical characteristics of metals and their handling in the 
body (toxicokinetics) can influence toxicity (toxicodynamics). Generalizing from mercury, 
arsenic, lead, aluminum, chromium, and manganese, it is clear that metal speciation 
influences mammalian toxicity. Methods used in aquatic toxicology to predict the 
interaction among metal speciation, uptake and toxicity are evaluated. A classification 
system is presented to show that the chemical nature of the metal can predict metal ion 
toxicokinetics and toxicodynamics. Essential metals, such as iron, are considered. 
These metals produce low oral toxicity under most exposure conditions but become 
toxic when biological processes that utilize or transport them are overwhelmed, or 
bypassed. Risk assessments for essential and nonessential metals should consider 
toxicokinetic and toxicodynamic factors in setting exposure standards. Because 
 3 
speciation can influence a metal’s fate and toxicity, different exposure standards should 
be established for different metal species. Many examples are provided which consider 
metal essentiality and toxicity and that illustrate how consideration of metal speciation 
can improve the risk assessment process. More examples are available at a website 
established as a repository for summaries of the literature on how the speciation of 
metals affects their toxicokinetics. 
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 There are important relationships between chemical speciation and toxicity for 
many toxic metals. Defining these relationships advances the understanding of 
mechanisms and treatments of toxicity and can improve risk assessment. This paper 
reviews the impact of speciation on the fate of metals; the interaction of 
biotransformation with absorption, distribution and elimination; the impact of speciation 
on metal toxicity; and how metal speciation might be incorporated into risk assessment. 
The impacts of valence state, isotope, associated ligands and inorganic and organic 
species on the fate of metals and their adverse effects are illustrated with many 
examples. Metal speciation and associated mechanisms of toxicity in mammals are 
reviewed with the objective of determining whether the relationships between speciation 
and metal fate and toxicity are empirical, or if models or systems can predict 
mammalian toxicity on the basis of chemical properties with the goal of their application 
in risk assessment. The companion paper presents the chemical separation and 
analytical detection methods most commonly used to speciate metals (Caruso et al., 
2005). It also presents a computational approach to metal speciation based on stability 
constants and concentrations of the metal and interacting ligands that can be used with 
some metals when physical separation and detection methods are not applicable or 
have not been developed.  
 It is well recognized that a metal’s species can influence its fate in the 
environment and in organisms, and therefore its toxicity. However, most regulations in 
international legislation concerning trace elements in food, the environment and 
occupational settings are based on the total amount of the element rather than 
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individual chemical forms (Larsen and Berg, 2001). Chemical speciation is a problem for 
the risk assessor because regulations concerning trace element exposure levels usually 
ignore the impact of chemical species on bioavailability and toxicity. Elements other 
than carbon are typically regulated as classes of compounds containing a named 
element rather than specific chemical forms (Duffus, 2001).  This review illustrates why 
metal speciation matters.  
 
What is Metal Speciation? 
 There is not a uniformly accepted definition of metal speciation. It has been 
suggested that such a definition would reduce confusion (Bernhard et al., 1986; 
Swietlik, 1998). A definition developed by the First, Second and Third International 
Symposia on Speciation of Elements in Toxicology and Environmental and Biological 
Sciences in 1991, 1994 and 1997 states: “Speciation is the occurrence of an element in 
separate, identifiable forms (i.e., chemical, physical or morphological state)” (Nieboer et 
al., 1999).  This definition is not limited to a strict chemical perspective as it recognizes 
that compounds of elements can occur in different physical states and that the state can 
affect the route and extent of exposure, uptake/absorption and the toxicodynamic 
results. The International Union for Pure and Appled Chemistry (IUPAC) developed a 
definition in 1997 recommending that speciation “Refers to the chemical form or 
compound in which an element occurs in both non-living and living systems. It may also 
refer to the quantitative distribution of an element”. In 2000 the IUPAC recommended 
definitions that distinguish among the following (Templeton et al., 2000): 
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i.   Chemical species (of an element): “Specific form of an element defined as to isotopic 
composition, electronic or oxidation state, and/or complex or molecular structure”, 
ii.  Speciation analysis (in chemistry): “Analytical activities of identifying and/or 
measuring the quantities of one or more individual chemical species in a sample”, 
and 
iii.  Speciation (in chemistry). “Distribution of an element amongst defined chemical 
species in a system.” 
Developers of the IUPAC definition suggested that speciation analysis be used when 
referring to the analytical activity of identifying and measuring species; that species 
transformation1 be used to describe the transformations that take place during cycling of 
the elements in geochemical and environmental contexts; and the term speciation be 
exclusively reserved to refer to the distribution of species in a particular sample or 
matrix (Templeton et al, 2000). These terms have been adopted by IUPAC (Nordberg et 
al., 2004) for inclusion in the next edition of the Compendium of Chemical Terminology, 
“The Gold book”. A recent review suggests that the IUPAC effort to define speciation, 
although admirable, has components that are difficult to understand; raises questions 
why the isotopic composition, a nuclear property, is considered a chemical property; 
and is narrowly defined, in that distribution is only one of several aspects of speciation, 
which should also include the processes of transformation, alteration and interaction 
_________________________________________________________________ 
Footnote1: Because this review focuses on metal speciation in mammals, we discuss 
transformation in biological organisms, e.g., biotransformation. 
_________________________________________________________________ 
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among the chemical species. These authors conclude “… speciation study is now just at 
the preliminary stage of its developmental process.” (Chai et al., 2004). Although there 
has been discussion between those involved in development of the definition that came 
out of the International Symposia and by the IUPAC, there are differences among these 
definitions. There does not appear to be any planned effort to harmonize these 
definitions. The focus of this review is that differences in metals can impact on the 
adverse response, and that risk assessment that does not recognize these variables is 
an oversimplification and does not take full advantage of current knowledge. As it is well 
known that chemical as well as physical properties can impact on the adverse 
response, we have considered both in this review.  
A variable that contributes to speciation is valence (the combining power of an 
atom, determined by the number of electrons in the outer shell of the atom that it will 
lose, add or share when reacting with another atom). Many metals have more than one 
biologically relevant valence state, discussed below. Another variable contributing to 
speciation is the isotope (one of two or more nuclides with the usual number of protons 
but differing in mass number due to a different number of neutrons). A third variable is 
the associated ligand. A fourth variable is particle size, a form of morphological state. As 
it has been repeatedly shown that particle size can influence distribution, especially in 
the lung, and the rate of solubility, we have considered particle size as a variable 
contributing to metal speciation. Speciation is expected to describe the chemical, 
physical and temporal behavior of chemical species in biogeochemical systems (Evans, 
2003). In this review we consider how physicochemical variables affect metal 
toxicokinetics and the resulting toxicodynamics in mammals.  
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The Metals and a New Database on the Impact of Metal Speciation on 
Toxicokinetics 
 Approximately 85% of the elements are metals and/or metalloids (elements that 
share properties of both metals and non-metals; B, Si, Ge, As, Sb, Te, Po and At). 
Many are essential and/or have considerable toxicity. Although the importance of metal 
speciation in toxicokinetics and toxicodynamics is appreciated, metal speciation has not 
been determined in most studies (Boisset, 2000). The impact of metal speciation on 
metal toxicokinetics and toxicodynamics in aquatic environments has been summarized 
and integrated to some extent (Ebdon et al., 2001; Paquin et al., 2002) but a focused 
summary of the effects of speciation in mammalian organisms is lacking. A database 
has been established to summarize and provide references for the published reports 
scattered throughout the periodical literature and in books that describe the impact of 
metal speciation on toxicokinetics in mammals 
http://www.mc.uky.edu/pharmacy/faculty/yokel/metal-toxicokinetics/. The objectives of 
this database are to begin to integrate this literature, illustrate the importance of 
speciation on metal toxicokinetics, and advance the refinement of risk assessment of 
metals beyond simply consideration of the metal independently of its chemical and 
physical form. A sample page from the database is shown in Figure 1.This database 
includes metals that are macronutrients (Na, K, Mg and Ca) as well as metals generally 
considered to be essential for human health in trace amounts (Cr, Co, Cu, Fe, Mn, Mo, 
Se and Zn), metals for which there is circumstantial evidence for essentiality (As, Ni, Si 
and V) and metals for which the circumstantial evidence is not as convincing (B, Cd, 
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Ge, Pb, Li, Rb, and Sn) (Uthus and Seaborn, 1996; Goyer and Clarkson, 2001). It also 
includes metals for which there is considerable toxicity (As, Be, Cd, Cr, Hg, Ni, Po, Ra, 
and Pb), intermediate toxicity (Co, Cu, Fe, Mg, Mn, Mo, Se and Zn) and those of lesser 
concern (Al, Ag, Am, Au, B, Ba, Bi, Ca, Ga, Ge, In, Li, Po, Pt, Sb, Sn, Sr, Te, Th, Ti, Tl, 
U and V) as indicated by the Toxicological Profiles (ATSDR), entries in POISINDEX, the 
Handbook on the Toxicology of Metals series (Friberg et al., 1979; Friberg et al., 1986), 
Patty’s Toxicology (Bingham et al., 2001) and (Goyer and Clarkson, 2001). It is 
apparent that there is considerable overlap between the metals that are essential and 
those that are toxic. 
 
Membrane Carriers Affect the Uptake and Toxicity of Many Metals 
 Many of the essential trace elements, the trace elements that are probably 
essential, and the elements that possibly have essential functions produce significant 
toxicity (World Health Organization, 1996). It might be anticipated that there are 
mechanisms to regulate their fate in mammals to maintain sufficient, as well as non-
toxic, concentrations. Membrane transport proteins (carriers or channel molecules in the 
plasma cell membrane) have been identified for most of these metals. Plasma 
membrane metal transporters may be quite selective, transporting one metal species 
but not another, due to selective binding sites that recognize specific chemical species. 
Some examples follow.  Cr(III) is unable to enter cells but Cr(VI) enters cells through 
membrane anion transporters (Singh et al., 1998). Many divalent cations including Cd, 
Co, Cu, Fe, Mn, Pb and Zn are substrates for the divalent metal transporter 1 (DMT-1 
also known as DCT-1 or nramp-2) which may mediate their intestinal uptake (Gunshin 
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et al., 1997; Picard et al., 2000). Transferrin also moves Fe across membranes (Hentze 
et al., 2004).  It appears that multidrug resistance-associated protein-2 (MRP2) mediates 
the biliary transport of glutathione complexes of As and cisplatin and perhaps Cu, Cd and 
Hg (Ballatori, 2002). Cu is also transported by a carrier, hCTR2, that is well conserved 
across organisms (Zhou and Gitschier, 1997; Lee et al., 2002). Forms of Cr, Mo and Se 
are structurally similar to sulfate and can serve as substrates for sulfate transporters 
(Ballatori, 2002). Selenomethionine is transported in the intestine by the same transporter 
that mediates methionine uptake (Moesgaard and Morrill, 2001). Se(IV) is taken up 
erythrocytes by an anion-exchange carrier (Suzuki et al., 1998). In addition to serving as 
a substrate for DMT-1, Zn transport is mediated by plasma membrane importers, hZip1, 
hZip 2 and ZnT-1 (Ballatori, 2002; Haase and Beyersmann, 2002), members of the 
cation diffusion facilitator family (Guffanti et al., 2002) and probably other carriers. A 
classic example of carrier-mediated flux is brain uptake by the large neutral amino acid 
transporter of the cysteine-methylmercury complex that mimics methionine (Aschner 
and Clarkson, 1988). These examples, and others in this review, illustrate that carriers 
can influence the fate and toxicity of specific metal species.  
 
Valence State and Isotope can Influence the Fate and Toxicity of Many Metals 
Many toxic metals have more than one biologically relevant valence state. These 
include: Ag(0, I and II), Am(III, IV, V and VI), As(III and V), Co(II and III), Cr(III and VI), 
Cu (0, I and II), Fe(0, II and III), Hg(0, I and II), Mn(II, III and IV), Mo(II, III, IV and VI), 
Ni(II and IV), Pu(III, IV, V and VI), Sb(III and V), Se(II, IV and VI), Sn(II and IV), Te(0, II, 
IV and VI), Tl(I and III), U(III and VI), V(IV and V), and Zn(0 and II). Biotransformations 
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among biologically relevant valence states and estimates of the relative toxicity of the 
different valences are shown in the above referenced website.  Valence can affect the 
absorption, distribution, biotransformation, and elimination of a metal and therefore its 
toxicity. For example, Cr(VI) is better absorbed than Cr(III) by the oral and dermal 
routes (Mertz, 1969; Langård and Norseth, 1979; Rowbotham et al., 2000). 
Comparisons have shown that Sn(II) is better absorbed orally than Sn(IV) (Hiles, 1974), 
U(VI) is better absorbed by inhalation than U(IV) (Stokinger, 1981; Eidson, 1994) and 
that Se(IV) is better absorbed by inhalation than Se(0) (Medinsky et al., 1981b). Studies 
in Caco-2 cells, an in vitro model of the gastrointestinal epithelium, revealed that Fe 
treatment decreased cellular uptake of Fe, Mn and Zn, suggesting these metals may 
utilize the same cell membrane transporters (Tallkvist et al., 2000). Ingested Fe(II) is 
absorbed by enterocytes via DMT-1 (Gunshin et al., 1997). DMT-1 mRNA levels in the 
duodenum increase markedly in response to Fe depletion (Gunshin et al., 2001; 
Philpott, 2002). It appears that neutral gelatinase-associated lipocalin is another Fe 
trafficking protein that transports Fe(III) rather than Fe(II) (Kaplan, 2002). Transferrin in 
mammals, and ovotransferrin in birds, also show metal valence selectively, transporting 
Fe(III) into cells, via receptor-mediated endocytosis (Evans and Holbrook, 1975).  The 
valence of a metal can also influence its excretion. As(V) is excreted more rapidly than 
As(III) (Hogan and Eagle, 1944). Therefore As(III) is retained to a greater degree than 
As(V) (Vahter and Norin, 1980; Lindgren et al., 1982; Vahter and Marafante, 1983). The 
relationships between valence state and absorption do not permit one to predict the 
relative absorption of two or more metal species based on their relative valences.  
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One of the best metals for demonstrating the variation in toxicity resulting from 
differing valence states is Hg. Ingested elemental Hg (Hg(0)) is not particularly toxic 
because of low gastrointestinal absorption (Bornmann et al., 1970). In contrast, inhaled 
Hg(0) is almost completely absorbed by the lungs (Berlin et al., 1969b). Hg(0) is 
oxidized to Hg(II) by catalase in erythrocytes (Magos et al., 1978), but not before some 
of the lipid-soluble Hg(0) crosses into the CNS (Klaassen, 2001). Absorption of 
inorganic Hg(I) and Hg(II) from the gastrointestinal tract is incomplete, but greater than 
Hg(0) (Miettinen, 1973; Sin et al., 1983; Yeoh et al., 1986; Sin et al., 1990). The highest 
Hg(II) concentrations are found in the proximal renal tubules, the primary site of toxicity 
after exposure to inorganic salts and Hg(0) vapor (Goyer and Clarkson, 2001). Inorganic 
Hg(I) and Hg(II) do not readily cross the blood-brain barrier whereas Hg(0) and methyl 
Hg readily do enter the brain by this route (Berlin et al., 1969a; Suzuki, 1969). Thus the 
major symptoms of organic Hg toxicity are neurological, including paresthesias, visual 
disturbances and muscle tremors. Neurotoxicity is more prominent with elemental Hg 
than with the inorganic forms. Inhalation of Hg vapor is the most common cause of Hg-
induced acute toxicity, producing chest pain, shortness of breath and renal tubular 
necrosis.  Chronic exposure to lower levels of Hg vapor produces a toxicity dominated 
by neurological signs and vasomotor disturbances, the “mad hatter” signs of increased 
excitability, tremors, and gingivitis (Smith, 1992). For Hg it is clear that there are distinct 
toxicities associated with each valence state and organic form. For example, Hg(I) is not 
as toxic as Hg(II), and until relatively recently was found in some skin creams for its 
antiseptic properties (Klaassen, 2001). The order of general toxic potential is: CH3Hg > 
Hg(II) > Hg(0) > Hg(I).  
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Another metal that exhibits contrasting toxicities as a result of different valence 
states is As. There are two primary families of inorganic As compounds – the arsenites 
(As(III)) and arsenates (As(V)). As(III) is the principal toxic form and tends to 
accumulate in vivo.  Mitochondrial respiration mediated by NAD-linked substrates is 
inhibited by As(III), due to reaction between the arsenite ion and the dihydrolipoic acid 
cofactor required for substrate oxidation (Goyer and Clarkson, 2001).  With acute As(III) 
overdose the fundamental lesion is endothelial cellular toxicity.  Chronic poisoning is 
subtle and leads to peripheral distal neuropathy, the most common motor neuropathy. 
As(V) competes with phosphate at a co-transporter in renal brush border membranes 
and in a transport system in the basolateral border of renal cells. The anion exchange 
transport system in erythrocytes also accepts As(V) as a phosphate congener 
(Clarkson, 1993).  
While there is much physiological conversion of As(V) to As(III), the subsequent 
metabolic pathway is more complex than previously conceptualized (Hughes, 2002; 
Aposhian et al., 2003). Oxidative methylation ultimately produces monomethylarsonic 
acid (MMA(V)) and dimethylarsinic acid (DMA(V)), which are less reactive with tissue 
constituents, less acutely toxic, and less cytotoxic than inorganic forms of As. However, 
there is evidence that the intermediate metabolites monomethylarsonous acid 
(MMA(III)) and dimethylarsinous acid (DMA(III)) are more toxic than As(V), As(III) or the 
analogous As(V) metabolites (Cohen et al., 2002; Hughes, 2002).  
Therefore, As toxicity is a function of 1) chemical form – the As(V) organic 
metabolites are less toxic than the inorganic forms; 2) solubility – As(III) is more soluble 
and toxic than As(V); 3) valence state – As(III) is more toxic to the CNS; and 4) duration 
 16 
of exposure.  At this time the best evidence suggests the order of toxic potential to be: 
MMA(III) > DMA(III) > As(III) > As(V) > MMA(V) > DMA(V). Thus, while organification 
appears to render metals such as Pb, Hg, and Sn more toxic, no simple generalizations 
for metalloids like As are evident. 
Examples illustrating the influence of valence on elimination are summarized in 
Table 1. These comparisons are from different studies that used different endpoints. 
Comparisons should only be made within, not across, studies.  
Using Hg and As as examples, it is clear that different valence states exhibit 
characteristic patterns of metal toxicity. Could one conclude that valence magnitude 
directly correlates with severity of toxicity?  The evidence does not generally support 
this, as shown in Table 2.  While such a relationship may apply for Hg where Hg(II) 
produces much more toxicity than Hg(I), this is not true for As(III), Cr(IV) or Cr(V), or 
Mn(III). What can be concluded is that severity of toxicity is dependent on how metal 
valence states interact with other physiological variables that determine the adverse 
response. Given the recognized effects of valence state on toxicokinetics, quality risk 
assessment should incorporate valence state-specific differences in toxicity.   
Some metals have more than one biologically relevant isotope, including 226Ra 
and 228Ra; the anthropogenic 232U and 233U and the natural 234U, 235U and 238U; 238Pu 
and 239Pu; and 228Th, 230Th and 232Th. The isotope has been reported to affect 
absorption. For example, 238Pu nitrate and dioxide were more rapidly absorbed in the 
dog following inhalation exposure than 239Pu nitrate and dioxide, whereas 239Pu nitrate 
was absorbed by the rat more rapidly than 238Pu nitrate (Morin et al., 1972; Park et al., 
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1972; Dagle et al., 1983). A simple relationship between the isotope and toxicity is not 
evident.  
 
Particle Size can affect Metal Deposition, Uptake and Toxicity 
The size of particles affects their deposition in the lung. Pulmonary introduction of 
particles > 10 µm diameter results in their deposition into the upper airway and usually 
mucociliary clearance into the gastrointestinal tract. Respirable particles ~ 5 µm 
diameter enter bronchioles and alveoli. Particles ~ 0.1 µm reach the alveoli, where the 
surface area is 100 m2, equivalent to a singles tennis court. Particles can be absorbed 
from the bronchioles and alveoli to enter the bloodstream, avoiding first pass hepatic 
clearance, as discussed in the Toxicological Profiles on Cd, Mn, Ni, Pb and Tl (ATSDR). 
Exposure to equivalent masses of an identically deposited substance may not produce 
the same response if particle sizes differ. For instance, ultrafine particles of Ti dioxide 
produced a greater inflammatory response in the rat lung than did larger particles 
(Oberdörster et al., 1994).  
 
Metal-Associated Ligands and Toxicity 
The ligand associated with a metal affects its chemical form, therefore the 
speciation of the metal. Ligands are atoms, ions or functional groups that bond to one or 
more central atoms or ions, usually metals, to form a complex. For example, the ligand 
associated with a metal can affect its solubility which can greatly influence lung 
absorption and clearance (Rhoads and Sanders, 1985). The associated ligand can also 
affect absorption from other routes as well as the distribution, biotransformation and 
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elimination of a metal. These effects on the metal’s fate can influence the adverse 
effects produced. For example, the absorption, distribution and subsequent toxicity of 
Al, which only exists in biological systems as Al(III), is influenced by its associated 
ligand and the stability of the Al-ligand complex. The predominant ligands and their 
stability constants have been used to predict the Al species in the calculations 
described in (Caruso et al., 2005). Intestinal Al absorption is facilitated by citrate (Goyer 
and Clarkson, 2001). In the absence of a complexing ligand such as citrate, hydrolysis 
of Al complexes results in sparingly soluble polynuclear species that are less well 
absorbed. Over 90% of plasma Al is bound to transferrin; the remainder is bound to low 
molecular weight ligands, predominantly citrate (Caruso et al., 2005). Al uptake into the 
brain is not well defined. One mechanism may involve transferrin, as occurs with 
receptor-mediated endocytosis of Fe(III) (Roskams and Connor, 1990). Citrate is a good 
candidate for involvement in brain Al uptake as well (Van Landeghem et al., 1998; 
Templeton, 1999). Al efflux from the brain probably does not involve transferrin-receptor 
mediated endocytosis as there are thought to be no available transferrin metal binding 
sites in brain extracellular fluid to mediate metal efflux by a transferrin-receptor 
mediated process (Bradbury, 1997). Al citrate appears to be transported out of the brain 
by mechanisms not involving the transferrin receptor (Yokel, 2001). 
Solubility can be influenced by the associated ligand. Solubility can affect 
absorption. Aqueous solubility enhances absorption from the lung and lipid solubility 
enhances dermal absorption. Solubility is a chemical property of metals, therefore a 
factor of metal speciation, which can impact on the adverse response of the metal. For 
example, following inhalation exposure, soluble forms of a metal enhance systemic 
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toxicity whereas respiratory toxicity is more likely from poorly soluble metals 
(Schlesinger, 1995). To illustrate, Cd from fumes was absorbed to a greater extent than 
Cd carbonate and Cd from pigments (Rusch et al., 1986; Jakubowski, 2001). The oral 
bioavailability of soluble Cr(VI) in potassium chromate appears to be higher than Cr(III) 
because if Cr(III) is not well complexed it precipitates at physiological pH (Darrie, 2001). 
However, the conversion of Cr(VI) by stomach acid to Cr(III) confounds this (Finley et 
al., 1997). Also contributing to the superior absorption of Cr(VI) may be its ability to 
enter cells by facilitated diffusion mediated by anion exchange and/or sulfate carriers 
(Wiegand et al., 1985) whereas Cr(III) cell entry is by passive diffusion and phagocytosis 
(Figure 2). The more soluble Cr(VI) salts are also better absorbed through skin than 
Cr(III), and presumably also by inhalation (Langård and Norseth, 1979). Greater 
absorption of the more soluble chemical forms of many other metals has been reported, 
including Ba by inhalation (Einbrodt et al., 1972; Cuddihy et al., 1974) and oral 
absorption (Johnson and VanTassell, 1991), Ti by the oral route (Schkroeder et al., 
1963), Mn after its inhalation (Vitarella et al., 2000; Dorman et al., 2001), Co by the oral 
route (Barnaby et al., 1968; Hollins and McCullough, 1971; Bailey et al., 1989; Ayala-
Fierro et al., 1999), Ni following inhalation (Benson et al., 1994; Hirano et al., 1994) and 
oral exposure (Ishimatsu et al., 1995), Pt by the inhalation route (Moore et al., 1975), 
and As after inhalation and oral exposure (ATSDR). Further information and references 
to the supporting literature can be found in the web-based database cited above. The 
greater absorption of the more soluble forms of many metals is thought to contribute to 
greater toxicity. Therefore one mechanism underlying differences in the toxicokinetics of 
metal species is their physico-chemical properties. 
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Observations concerning metal-associated ligands are largely empirical, so a 
question is whether one can identify a model to predict metal ion reactivity and metal-
ligand stability. The importance of the associated ligand is examined in more detail 
below with respect to the toxicity of Pb.  
Pb is a metal with a single prominent valence state (i.e., II) that avidly forms 
complexes in physiological solutions. Some factors that enhance absorption and 
distribution have been identified. The major determinant of absorption is the solubility of 
the Pb salt, and the process appears to be facilitated diffusion (Goyer and Clarkson, 
2001).  Transport through an anion exchange channel is a primary means of Pb entry 
into cells, and appears to involve a Pb carbonate anion – for example, Pb(CO3)Cl- 
(Simons, 1986).  In contrast, Pb(II) transport across the blood-brain barrier has been 
hypothesized to be by passive diffusion of PbOH+ (Deane and Bradbury, 1990). Notably, 
free hydrated Pb(II) appears to stimulate protein kinase C (Markovac and Goldstein, 
1988; Long et al., 1994), to enter neuronal L-type voltage-sensitive Ca(II) channels 
(Clarkson, 1993), and may also enter neurons via store-operated Ca(II) channels 
(Kerper and Hinkle, 1997). Finally, a significant amount of intracellular Pb(II) is bound to 
protein in astrocytes, neurons, renal tubular cells, and erythrocytes.  
Another mechanism by which the associated ligand can influence toxicokinetics, 
and therefore toxicodynamics, is by influencing the process that moves metals cross 
membranes. If the metal-ligand complex is a substrate for carrier-mediated transport, 
that process will add to the transmembrane flux provided by diffusion. Among the many 
examples of the impact of the associated ligand on the fate of metals is the greater oral 
absorption of selenomethionine and selenite than elemental Se, probably due to their 
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carrier-mediated uptake (McConnell and Cho, 1965; Anundi et al., 1984). Cd bound to 
high molecular weight circulating proteins is mainly trapped by the liver whereas Cd 
bound to low molecular weight species, such as metallothionein, distributes into the 
kidney and appears in the urine (Jakubowski, 2001). CH3Hg forms a complex with L-
cysteine that resembles methionine and is transported into the brain by the L-type 
neutral amino acid carrier (Aschner and Clarkson, 1989). Organic forms of As are 
excreted more rapidly than inorganic forms (Coulson and al, 1935; Overby and Frost, 
1962; Morgareidge, 1963). The several-hundred fold greater concentration of As in bile 
than plasma (Klaassen, 1974) may be mediated by multi-drug resistance protein 2 
transport of glutathione-As complexes (Ballatori, 2002). The relationship between metal-
associated ligands and toxicity has also been examined for Mn(II), and some important 
toxicokinetic factors identified.  Approximately 87% of plasma Mn(II) is bound to albumin 
with most of the balance bound to low-molecular-mass ligands; most Mn(III) is bound to 
transferrin (Aschner, 2000).  Mn(II) can cross the blood-brain barrier as the citrate, the 
free divalent ion, or bound to transferrin (Crossgrove et al., 2003), occurring via 
transferrin receptor-mediated endocytosis and other transport processes (Crossgrove 
and Yokel, in press).  Efflux from the brain appears to occur by simple diffusion (Yokel 
et al., 2003).  Astrocyte toxicity correlated with the Mn-associated ligand. Solubility of 
the Mn(II) salt and intracellular Mn(II) concentration are the major determinants. The 
order of toxic potential was MnCl2 > MnSO4 > MnPO4 (Erikson et al., 2002).  Mn(II) 
accumulation in astrocytes and uptake across the blood-brain barrier appear to occur 
via one or more transport processes shared with Ca(II) (Aschner et al., 1992; 
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Crossgrove and Yokel, in press). Thus, it is clear that the metal-associated ligand can 
profoundly affect bioavailability and the effects of exposure.   
 
Organic Versus Inorganic Metal Species 
 Comparisons of the relative absorption of inorganic versus organic metal species 
generally suggest greater absorption of organic forms. This is illustrated with Hg. 
Organic mercurials, such as CH3Hg, are almost completely absorbed from the 
gastrointestinal tract and are well absorbed following dermal exposure (Swensson, 
1952; Joselow et al., 1972; Nordberg and Skerfving, 1972). These Hg species are 
widely distributed throughout the body because of their lipophilic nature (Klaassen, 
2001). In contrast, the oral bioavailability of inorganic Hg species is considerably lower 
(Sollman and Schreiber, 1936; Rahola et al., 1973). Organotins are often better 
absorbed than inorganic Sn species but this varies considerably with the organotin 
presumably by all routes of exposure (Heath, 1963; Brüggemann et al., 1964; Bridges et 
al., 1967; Mazaev et al., 1976; Winship, 1988). Organolead compounds are better 
absorbed by the dermal route than inorganic Pb species (Verity, 1995). Organic Se is 
better absorbed orally than inorganic forms (Thomson et al., 1975; Bopp et al., 1982) 
(Cummins and Kimura, 1971; Cary et al., 1973; Medinsky et al., 1981a). An exception to 
the greater absorption of organic than inorganic species may be As (Bettley and 
O'Shea, 1975; Munro, 1976; Crecelius, 1977; Charbonneau et al., 1978; Pomroy et al., 
1980; Vahter and Norin, 1980; Marafante et al., 1981; Tam et al., 1982; Vahter and 
Marafante, 1983; Marafante et al., 1984). Another exception is the ability of some amino 
acids to decrease oral Co, Cu and Ni absorption (Taylor, 1962; Baker and Czarnecki-
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Maulden, 1987; Johnson and Lee, 1988; Pott et al., 1994; Templeton et al., 2000),  
presumably by chelation through formation of a coordination complex. In contrast, some 
metals bind to specific amino acids forming species that are substrates for uptake 
carriers. For example, this facilitates the oral absorption of Cu (Wapnir and Stiel, 1986) 
and distribution to the brain of methylmercury (Aschner and Clarkson, 1988). 
Distribution, biotransformation and excretion of organic and inorganic metal forms often 
differ as well. The greater toxicity of organic species of several metals, including Pb and 
Bi, has been attributed to greater penetration of the blood-brain barrier (Clarkson, 
1979). Metallothionein-bound Cd distributed differently than ionic Cd species. The Cd-
MT complex is transported to the kidney, filtered, and reabsorbed into the proximal 
tubule via a mechanism involving receptor-mediated endocytosis (Foulkes, 1978; 
Squibb et al., 1984; Dudley et al., 1985; Dorian et al., 1992). Some organic Se species 
are retained in tissue longer than inorganic species, presumably due to incorporation 
into proteins (Sternberg and Imbach, 1967; McConnell and Hoffman, 1972; Hsieh and 
Ganther, 1975). This also results in lower rates of organic, than inorganic, Se excretion 
(Mangels et al., 1990). Protein-bound metals are not cleared by the kidney as rapidly as 
small molecular weight non-protein bound species. The ratio of renal to fecal metal 
elimination is also influenced by the species of As. Whereas the ratio is ~ 1 for organic 
As, more inorganic As is excreted in feces than in urine (Coulson and al, 1935; Overby 
and Frost, 1962; Morgareidge, 1963). Ni carbonyl is excreted by the lungs. After it has 
been degraded, the metabolites appear in the urine (Sunderman and Selin, 1968; 
Kasprzak and Sunderman, 1969), as also occurs after Ni chloride and sulfite 
administration (English et al., 1981; Carvalho and Ziemer, 1982; Medinsky et al., 1987).  
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More illustrations of the differences in metal toxicokinetics of organic versus inorganic 
metals can be found in the toxicokinetics database mentioned above.  
 
Biotransformation Can Change Metal Fate and Toxicity 
Biotransformation can have a profound impact on toxicokinetics and 
toxicodynamics. The resultant metal species may have a different ligand and/or valence 
state, changing absorption and thereby toxicity.  For example, dissolution by gastric 
juice has been suggested to increase Ag, Al, B, Ba, Be and Zr solubility and potentially 
absorption (Smith and Carson, 1977; Stokinger, 1981; Johnson and VanTassell, 1991; 
Reiber et al., 1995) (Culver et al., 2001; Mroz et al., 2001), although Zr and Al have also 
been suggested to subsequently become less soluble at the higher pH of the intestine 
(Stokinger, 1981; Reiber et al., 1995). In the absence of a complexing ligand such as 
citrate, hydrolysis of Al(III) complexes results in sparingly soluble polynuclear species 
that result in reduced absorption. Dietary phytates produce insoluble, non-absorbed 
complexes with Cu, Fe, Mn and Zn at the gut pH (Windisch, 2002).  Phytates similarly 
decrease Cr(III) absorption but oxalate enhances it, by preventing formation of insoluble 
Cr oxides (Chen et al., 1973).  
 Biotransformation can also affect metal distribution, elimination and toxicity. 
Excellent examples are Hg and As. Hg(0) and organomercurials, such as methyl, ethyl 
(in thimerosal, sodium ethylmercurithiosalicylate) and phenyl mercury, can be converted 
to inorganic Hg(II) in nearly all organs, including the brain. Redistribution of inorganic 
Hg(II) out of the brain and other organs is slow (Magos et al., 1978; WHO, 1990, 1991; 
Foulkes, 2001).The prolonged residence time in the brain is thought to contribute to Hg 
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toxicity to astrocytes and microglia (Charleston et al., 1996). A substantial portion of 
As(V) is rapidly reduced to As(III) in the body in association with thiol oxidation 
(Abernathy et al., 1999). As noted in the above discussion on how valence state and 
isotope can influence metal fate and toxicity, As(III) is more extensively retained than 
As(V). There is also in vivo interconversion of V(IV) and V(V) (Rydzynski, 2001); 
oxidation of Mn(II) and Fe(II) to Mn(III) and Fe(III) (Gibbons et al., 1976; Kono et al., 
1976; Ezra et al., 1984; Archibald and Tyree, 1987); and reduction of Cr(VI), and Pt(IV) 
to Cr(III), and Pt(II) (De Flora and al, 1986; Petrilli et al., 1986; De Flora and al, 1989; 
De Flora et al., 1989; Zhong et al., 1997). Cr(VI), being unstable in vivo, rapidly reduces 
to Cr(V) which is labile and coverts to Cr(IV) and ultimately to Cr(III), which is quite 
stable due to its complexation with DNA and proteins (Kasprzak, 1991). On the other 
hand, there are many metals with completely filled inner electronic orbitals that do not 
readily undergo in vivo biotransformation among valence states, such as Al, Pb, Sn, Tl 
and Zn.  
There are examples where valence changes impact distribution (the rates of cell 
entry of V, Fe and Cr and the protein to which Mn binds) (Gibbons et al., 1976; 
Danielsson et al., 1982; Langård, 1982; Harris et al., 1984; Templeton et al., 2000) and 
elimination (the clearance of Mn and Cr) (Gibbons et al., 1976; Norseth et al., 1982). Be 
and Th form insoluble colloids and Gd forms insoluble carbonate and phosphate 
precipitates in blood that are then taken up the reticuloendothelial cells (Clarkson, 1979; 
Stokinger, 1981; Dean et al., 1988). Ag precipitates and is then transformed into 
complexes or elemental metal that accumulates in the skin, producing a blue-gray 
discoloration (Danscher, 1981). Cd binds to metallothionein and U binds to bicarbonate 
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but the free metals are released in the kidney, producing nephrotoxicity (Bassett et al., 
1948; Cherian and Shaikh, 1975; Squibb and Fowler, 1984). Tetraalkyl tins are 
converted to highly toxic trialkyl derivatives (Stoner et al., 1955). Tetraalkyl Pb is 
converted to tri-, dialkyl- and to some extent inorganic Pb (Cremer, 1965). Se and Te 
are dimethylated, in a detoxification pathway, to species that are exhaled, producing a 
characteristic garlic breath (McConnell and Portman, 1952; Taylor, 1996). Organic 
species of elements are generally excreted faster than inorganic forms (Apostoli, 1999). 
Many more examples illustrating these points are in the above mentioned database. 
Biotransformation may be mediated by non-enzymatic as well as enzymatic 
processes. For example, Cr(VI) can be reduced non-enzymatically by glutathione to the 
more toxic Cr(III) (Kortenkamp et al., 1989). It seems that Cr(VI) can also be reduced 
enzymatically by glutathione reductase (Gunaratnam and Grant, 2001).  
The rates of non-enzymatic and enzymatic biotransformation processes can 
influence whether biotransformation occurs within the residence time of the metal 
species in vivo. This is described in (Caruso et al., 2005). For example, the mean 
residence time of water in Al(H20)63+ is ~ 1 second, the complexation half-life for 
Al(H20)63+ by citrate is ~ 1 to 2 minutes and by fulvic acid 7 to 115 seconds (Lopez-
Quintela et al., 1984; Plankey and Patterson, 1987; Burgess, 1992). The exchange half-
life of Al from the Al-fulvic acid complex to an Al-Chelex 100 complex is ~ 4 to 20 
minutes at the weaker and ~ 2 to 15 hours at the stronger Al binding site (Sekaly et al., 
1999). The latter exceeds the initial half-life of Al in the mammal (Wilhelm et al., 1990). 
Thus, equilibrium among Al species may not occur in vivo before most Al is eliminated. 
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Models to Predict Toxicity that Incorporate Speciation 
Models have been developed for aquatic toxicology to predict the impact of metal 
speciation on the toxic response.  The most extensively studied system is the free-ion 
activity model (FIAM) which assumes that simple ionic species interact with binding 
sites on the cell surface. This model postulates that the biological response elicited by a 
dissolved cationic trace metal is a function of the free metal ion concentration (Morel, 
1983). The toxic response of aquatic organisms generally relates to the free ion 
concentration. Examples of metals that conform to this model include Cd, Cu, Fe, Mn, 
Ni, Pb and Zn (Campbell, 1995). There are exceptions. For example, toxicity to green 
alga was not proportional to the free Al concentration (Parent et al., 1996). It was 
thought that the Al complexing ligand (fulvic acid) interacted with alga to modulate the Al 
response. The FIAM is further limited by the observation that the % of free ions in 
solution in the environment is generally less than 2% (Donard, 2001) and often cannot 
be determined analytically. In seawater most Ni, Mn(II), Zn, Co(II) and Fe(II) are present 
as free aquo ions. However, Cd, Cu(I), Ag(I) and Hg(II) complex with chloride (Cl-); 
Cu(II) and Pb(II) with carbonate; and Fe(III) and Al with hydroxide ions (Byrne et al., 
1988).  
The biotic ligand model (BLM), which also predicts the impact of speciation on 
the adverse response, has generated considerable interest for its potential to perform 
risk assessment of metals in aquatic environments (see (Paquin et al., 2002) and the 21 
companion papers in the same journal issue). This is a chemical equilibrium-based 
model founded on the concept that metal binding to defined sites (biotic ligands) at the 
point of action, typically the cell surface, is associated with acute toxicity. It recognizes 
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that the interaction between the metal’s chemistry and the physiology of the target 
organism affects the adverse response, and therefore, risk assessment. It differs from 
the FIAM in its emphasis on the biotic ligand, the site of toxicity of the organism. It 
assumes that there is competition for binding to the biological ligand among the cationic 
metal and dissolved organic matter; inorganic ligands such as hydroxides, chlorides and 
carbonates; and competing cations such as Na+, Ca(II), Mg(II) and H+ ions. This model 
recognizes that metal speciation affects metal binding to sites of toxicity. Chemical 
considerations for the FIAM, BLM and other models are discussed in (Caruso et al., 
2005). Reasonable agreement has been found between experimental toxicity endpoints 
and those predicted by the BLM. However, most studies have been conducted using 
metal concentrations in excess of those seen in the environment (Batley, 2003). The 
BLM has been primarily used to predict toxicity at 96 hours after 3 or 24 hour gill binding 
assay exposures because they are more convenient to conduct and provide more 
consistent data than longer exposures (Niyogi and Wood, 2003). Application of the BLM 
to chronic exposure has been performed (Niyogi and Wood, 2003), and provides 
guidance to further development of this model. There is an absence of similar models 
that incorporate the many aspects of metal speciation for mammalian organisms. 
Although models have been developed for toxicity-inducing metals in mammalian 
organisms, they have seldom considered metal speciation. A noteworthy model to 
predict metal ion reactivity and metal-ligand stability is the classification system 
proposed by Nieboer and colleagues (Nieboer and Richardson, 1980; Nieboer et al., 
1999). This system was developed from fundamental properties of metal ions.  It is 
based upon electronegativity, the tendency for the metal atom to become negatively 
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charged, and coordination number, the number of sites at which complexed ligands 
are attached to a metal ion. To classify metal atoms according to their ability to form 
covalent bonds the index (χm)2r is utilized, where χm is the electronegativity and r is the 
ionic radius of the species with the most common coordination number.  This index is 
interpreted as comparing valence orbital energy with ionic energy, and thus reflects the 
relative ability to form covalent versus ionic bonds.  That is, it is a covalent index.  A 
second index was devised as z2/r to represent ionic interactions, where z is the ion 
charge and r is defined as above. 
The graph of these two values for ions of 36 metals and two metalloids is shown 
in Figure 3. All groups of the periodic chart containing metals are represented, as are all 
periods of the chart with the exception of the actinides. With this plot Nieboer and 
Richardson (1980) also separated metal and metalloid ions into three groups, 
reproducing the traditional groupings of Class A (‘hard’ acids, oxygen donor-atom 
seekers), Class B (‘soft’ acids, nitrogen/sulfur donor-atom seekers), and intermediate 
metal ions which display ambivalent affinity for donor-atom types (Hancock and Martell, 
1996).  The purpose of this classification system was to predict metal-ligand stability 
and toxicity based on metal ion properties. 
 For a fixed value of the ionic index in Figure 3, toxicity generally increases with 
increasing magnitude of the covalent index. For example, Hg(II) produces more toxicity 
than Ca(II). Conversely, for a fixed value of the covalent index, toxicity generally 
increases with increasing magnitude of the ionic index. For instance, As(III) produces 
more toxicity than Cu(II).  In addition, for a fixed value of the covalent index, stability 
with nearly all ligands correlates positively with the ionic index. Similarly, for a fixed 
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value of the ionic index, stability generally increases with increasing values of the 
covalent index. For example, Pb(II) functionally displaces Ca(II) in neurons by impeding 
Ca(II) entry through membrane voltage-sensitive channels (Suszkiw et al., 1984) and 
exhibiting greater potency to activate Ca(II)-dependent enzymes and proteins (Shao 
and Suszkiw, 1991; Long et al., 1994; Kern et al., 2000)  Cd(II) has a similar action on 
voltage-sensitive Ca(II) channels.  Thus, this model suggests that increased metal-
ligand stability results in increased toxicity. 
This system is based on general trends in fundamental properties of metal ions, 
and has evident limitations. Nonetheless, it is an attempt to bring organization to the 
knowledge of metal-ligand associations in order to provide predictive value for toxicity.  
Like the FIAM and BLM, it is a laudable step in the right direction. An analogous system 
for metal-ligand stability based on ligand (‘hard’/‘soft’ base) properties might also be 
useful. 
Speciation information has seen only limited application in physiologically-based 
models of the kinetics of metals. A model for Cr has parallel absorption and disposition 
schemes for Cr(III) and Cr(VI), recognizing the importance of valence on the kinetics 
and toxicity of Cr (O'Flaherty, 1996). However, these models have largely ignored 
speciation issues and have only addressed 'bulk movement' of metals. 
Similarly, although the importance of speciation has been recognized in 
epidemiology studies with Al (Gauthier et al., 2000), Hg (Vahter et al., 2000) and Ni 
(Teaf et al., 2004), the number of epidemiology studies incorporating speciation as a 
variable is quite limited.  
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Risk Assessment Considerations for Essential and Toxic Metals  
Risk assessment can be defined as a characterization of the potential adverse 
health effects of human exposure to environmental hazards. Steps in risk assessment 
include a description of potential adverse health effects associated with chemical 
exposure, extrapolation of results to estimate the extent of human health effects under 
certain conditions of exposure, and uncertainty characterization (Williams and 
Paustenbach, 2002). A comprehensive review of regulatory limits set for metals is 
beyond the scope of this paper; however, important exposure limits include those set for 
occupational (e.g., TLV) or environmental (e.g., Reference Doses (RfDs) and Reference 
Concentrations (RfCs)) exposures.  
A special challenge for toxicologists is the risk assessment of metals that are 
essential and toxic. The dose-response curve for these nutrients is U-shaped where 
deficiency or abnormally high exposures can result in adverse effects (Olin, 1998). 
Essential metals are obtained from the diet and are often under tight gastrointestinal 
and hepatobiliary control. Oral toxicity from most essential metals occurs under high 
dose conditions when these normal homeostatic pathways are overwhelmed. For 
example, acute Fe poisoning occurs when receptor-dependent processes are saturated 
and ingested Fe is passively absorbed down concentration gradients (Mills and Curry, 
1994). Poisoning may also result from exposure to a more toxic form of the metal, such 
as a more toxic valence state (e.g., Cr(VI) vs. Cr(III)) or a more bioavailable form.  
Cr provides a good example to highlight key issues related to risk assessment of 
an essential and toxic metal. Cr speciation determines its essentiality and 
carcinogenicity (Katz, 1991). It occurs primarily as Cr(III), which is the most stable form, 
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as well as Cr(VI). Elemental Cr(0) does not occur naturally. Cr(III) is an essential trace 
metal that improves glucose tolerance (Kobla and Volpe, 2000) and is required for the 
metabolism of insulin (Katz, 1991; Rowbotham et al., 2000). Cr(III) is typically insoluble 
in water, is poorly absorbed from the gastrointestinal tract, and has low oral toxicity. 
Cr(III) forms stable complexes with glutathione, ascorbic acid, and other ligands (Yuann 
et al., 1999; Gaggelli et al., 2002). Cellular uptake of Cr(III) is low (Figure 2), and it is not 
mutagenic (De Flora et al., 1990). Likewise, there is little or no evidence that Cr(III) 
compounds are carcinogenic in experimental animals or humans (Katz and Salem, 
1993).  
In contrast, Cr(VI), including chromate (CrO42-) and dichromate (Cr2O72-) species, 
represent anthropogenic forms of Cr. These ions are water soluble and are powerful 
oxidizing agents. When ingested, Cr(VI) can be reduced by stomach acids to the less 
toxic Cr(III) form (De Flora et al., 1987; Finley et al., 1997). Acidic drinks (e.g., 
lemonade, coffee) can promote Cr(VI) reduction. Reduction of Cr(VI) to Cr(III) is an 
important factor when considering the risk associated with Cr ingestion. Indeed, there is 
little data to support the notion that ingestion of Cr(VI) is associated with cancer. 
Scientific evidence suggests Cr(VI) is not carcinogenic in humans via the oral route at 
permissible drinking-water concentrations (Kerger et al., 1996; Proctor et al., 2002; 
Paustenbach et al., 2003). 
Inhaled particulate forms of Cr(VI) produce respiratory tract toxicity including lung 
and nasal cancers. Clinical signs associated with Cr(VI) inhalation include bronchial 
asthma, mucosal ulceration, and perforated nasal septum (Feron et al., 2001). 
Sinonasal and lung cancers have also been observed in people exposed to relatively 
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insoluble forms of Cr(VI) (Feron et al., 2001). Cr(VI) enters cells through membrane 
anion (sulfate/phosphate) transporters where it is subsequently reduced to transient 
Cr(V) and more stable Cr(III) forms (O'Brien et al., 2003). Cr(III) and Cr(V) can 
covalently interact with nucleic acids and other macromolecules (Singh et al., 1998). 
Cr(III), Cr(IV), and Cr(V) can react with DNA and induce DNA oxidation and genotoxicity 
(O'Brien et al., 2003). Cr provides a clear example where metal speciation must be 
accounted for in the risk assessment process. 
Toxicity from essential metals can also occur when normal homeostatic control 
mechanisms are bypassed. For example, inhalation exposure can result in portal of 
entry or systemic effects. Inhalation portal of entry effects relate to nasal or pulmonary 
actions. Rhinitis and nasal septum perforations are associated with exposure to Cr(VI) 
and As(III) (Sunderman, 2001). Nasal irrigation of Zn sulfate is associated with olfactory 
epithelial degeneration, hyposmia, and anosmia (Cancalon, 1982; Sunderman, 2001). 
Systemic toxicity can also occur from inhalation exposure. Metal fume fever is a well-
documented acute respiratory disease observed in welders and others who inhale 
ultrafine particles of essential and possibly essential metals (e.g., Cu, Mn, Ni, V, or Zn) 
as well as nonessential metals (e.g., Al, Be, Cd) (Gordon and Fine, 1993). Systemic 
toxicity is not confined to the lung. Inhalation of Fe and Mn provide prime examples 
where neurotoxicity can occur. 
Toxicity can occur following parenteral injection. For example, individuals 
receiving total parenteral nutrition (TPN) were found to be at risk for Mn neurotoxicity. 
As with other forms of Mn poisoning, these patients developed elevated serum Mn, they 
had symmetrical high intensity magnetic resonance imaging (MRI) lesions in the globus 
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pallidus consistent with Mn accumulation at this site, and they developed characteristic 
psychiatric symptoms and clinical signs of Mn-induced neurotoxicity (Takagi et al., 
2002). Withdrawal from the TPN supplement significantly decreased blood and brain Mn 
levels (Kafritsa et al., 1998; Bertinet et al., 2000). Dermal toxicity can be a concern as 
well (Kirchner, 2002). Exposure to essential as well as non-essential metals, such as 
Au, Co, Cr and Ni, can produce contact dermatitis.  
Recommended Dietary Allowances (RDAs) or Acceptable Daily Intakes (ADIs) 
are developed for essential metals. Uncertainty factors used by the nutrition and 
toxicology communities to set exposure guidelines for essential metals are not shared.  
In particular, toxicity exposure limits (e.g., RfDs) typically rely on animal data and 
incorporate uncertainty factors to account for interspecies differences in sensitivity. Most 
RDAs are based on human data, thus no additional uncertainty factors are needed to 
account for extrapolation of animal data to human risk assessment. The US EPA also 
uses a larger uncertainty factor (i.e., up to 10) to describe intraspecies differences than 
those used by nutritionists to derive acceptable daily intakes (Mertz, 1995; Olin, 1998). 
These disparate approaches can result in overlap between intakes deemed necessary 
with those considered potentially toxic (Olin, 1998; Goldhaber, 2003). For example, the 
World Health Organization (WHO, 1973) concluded that consumption of 8-9 mg Mn/day 
is "perfectly safe” while the current Reference Dose for Chronic Oral Exposure (RfD) is 
10 mg Mn/day. The tolerable upper intake level (UL), which is considered the highest 
level of daily nutrient intake that is likely to pose no risk of adverse health effects to 
almost all individuals in the general population, set for Se and Zn are lower than the 
current RfD values for these essential nutrients (Goldhaber, 2003).  Most nutritional 
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levels do not consider speciation despite the wealth of information indicating that 
valence state and ligand binding dramatically alter the bioavailability of essential metals. 
Conclusions 
In this review the relationships between metal speciation, toxicokinetics and 
toxicodynamics have been examined, focusing particular attention on the factors of 
valence state, metal-associated ligands and biotransformation. Examples of speciation-
dependent induced toxicity have been reviewed. An attempt has been made to develop 
useful generalizations relative to these factors. Among these generalizations it is 
evident that different metal valence states exhibit characteristic patterns of toxicity, and 
that the magnitude of the valence state does not correlate with the severity of the 
adverse response. Moreover, organic metal species are not always more toxic than 
inorganic forms of the same metal. Furthermore, the nature of the metal-associated 
ligand can profoundly affect metal ion toxicokinetics and exposure effects. As a result of 
this latter observation, a published classification system based on metal properties has 
been proposed to have predictive value related to toxicity.  
Evaluation of this system indicated that the severity of the adverse response was 
generally related to the stability of the metal-ligand complex. Thus, this model might be 
utilized to link metal speciation with human health risk assessment. Models have been 
developed for aquatic toxicology that focus on the free-ion activity and the interaction 
between metal and site of action of toxicity of the organism. Comparable models have 
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Figure 2. Pathways involved in Cr metabolism in erythrocytes (bottom) and formation of 
DNA lesions by Cr(VI) (top). Cr(III) is poorly absorbed by cells while Cr(VI) is brought 
into the cell via sulfate anion channels. Once in the cell Cr(VI) is reduced to Cr(III) – 




Figure 3. Relationship between ionic and covalent indices for the metal and metalloid 
ions. The covalent index has been divided into three classifications, Class A (oxygen 
seeking; bottom), intermediate (center) and Class B (sulfur and nitrogen seeking; 






 Table 1.  Examples of the influence of valence on the clearance of metals. 
Metal in valence state in left column cleared 
more rapidly than in valence state in next 
column 
Cleared Reference 
V(V) V(IV) From lung (Edel and 
Sabbioni, 1988) 






Cr(IV) Cr(III) Into bile (Norseth et al., 
1982) 







Mn(II)α2-macroglobulin Mn(III) transferrin From 
mammal 
(Gibbons et al, 
1976) 
As(V) As(III) Into urine  (Hogan and 
Eagle, 1944) 
(Cikrt and Bencko, 
1974) 
(Na3AsO3) As(III) (Na2HAsO4) (As(V) Into bile (Cikrt and Bencko, 
1974) 
As(V) As(III) From 
organs 
 




(Boyd and Roy, 
1929; Goodwin 
and Page, 1943; 
Abdallah and Saif, 
1962) 
Sb(V) Sb(III) Into urine (Gellhorn et al., 
1946; Edel et al., 
1983) 
Sb(III) Sb(V) Into feces (Otto and Maren, 
1950; Edel et al., 
1983) 













 As(III) As(V) (Hughes, 2002; 
Aposhian et al., 2003) 
 
Cr(III) < Cr(VI) Cr(IV), Cr(V) 
intermediates 
Cr(III) < Cr(VI) (Kasprzak, 1991; 
Templeton et al., 2000) 
 
Hg(I) Hg(II)  
(Klaassen, 2001) 
Mn(II) Mn(III) Mn(IV) (Chen et al., 2001; 
Reaney et al., 2002) 
 
Te(II) Te(IV) Te(VI) (Goyer and Clarkson, 
2001) 
 
U(IV) U(VI)  ATSDR Toxicological 
Profile for Uranium 
 
 
